InvestorsHub Logo
Followers 1
Posts 521
Boards Moderated 0
Alias Born 08/16/2017

Re: mtc44380 post# 79507

Friday, 08/18/2017 6:40:37 PM

Friday, August 18, 2017 6:40:37 PM

Post# of 80867
For me the biggest current issue is the protein bar manufacturing change. It doesn't make sense unless MusclePharm wasn't making any profit because the supplier was too expensive and made it impossible sell to MP customers with sufficient margin. Why else would MP switch suppliers to an inferior product with bad feedback on quality from customers?

Is MP willing to roll the dice and see how many customers they lose because they couldn't win anyway with the better product due to insufficient margins?

If the CEO converts his debt to equity on or before November 7 it saves the company a ton of expenses that can be passed to the bottom line where there is a chance at EPS profitability. Even if the outstanding shares double via dilution, EPS profit can present the company with an opportunity for a real valuation multiple which should be somewhere between 5x-10x 12 month EPS.

Then growth will be key to multiple expansion and shareholder appreciation.

If MP continues to flounder with losses and product rejection, then the story will be same as the recent chart momentum.

Your question about buying shares at $1.40 I answered. I posted my screenshot showing I did. I may sell before November 7 if no news or bad news but a conversion of debt to equity with OS of 24m shares and 50 cents of EPS would value the company at $2.50-$5.00 a share. I don't think MP can hit 50 cent 12 month EPS yet but it's not out of the realm of possibility if the $18m in debt and 10%-15% debt service payments are retired via equity conversion.